Prevention of cardiovascular disease with a polypill - Reply

被引：0
|
作者：
Gaziano, Thomas A.
Opie, Lionel H.
Weinstein, Milton C.
机构：
[1] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
[2] Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst Heart Res, ZA-7925 Cape Town, South Africa
[3] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA
来源：
LANCET | 2007年 / 369卷 / 9557期
关键词：
D O I：
10.1016/S0140-6736(07)60098-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [31] Polypill Strategy in Secondary Cardiovascular Prevention
    De la Rosa, Alan
    Arrington, Kedzie
    Desai, Rohan
    Acharya, Prakrati C.
    CURRENT CARDIOLOGY REPORTS, 2024, 26 (05) : 443 - 450
  • [32] Polypill strategy for secondary cardiovascular prevention
    Arnold, N.
    Koenig, W.
    Nitschmann, S.
    INNERE MEDIZIN, 2023, 64 (05): : 510 - 512
  • [33] Polypill Strategy in Secondary Cardiovascular Prevention
    Castellano, Jose M.
    Pocock, Stuart J.
    Bhatt, Deepak L.
    Quesada, Antonio J.
    Owen, Ruth
    Fernandez-Ortiz, Antonio
    Sanchez, Pedro L.
    Marin Ortuno, Francisco
    Vazquez Rodriguez, Jose M.
    Domingo-Fernandez, Alexandra
    Lozano, Inigo
    Roncaglioni, Maria C.
    Baviera, Marta
    Foresta, Andreana
    Ojeda-Fernandez, Luisa
    Colivicchi, Furio
    Di Fusco, Stefania A.
    Doehner, Wolfram
    Meyer, Antje
    Schiele, Francois
    Ecarnot, Fiona
    Linhart, Ales
    Lubanda, Jean-Claude
    Barczi, Gregory
    Merkely, Bela
    Ponikowski, Piotr
    Kasprzak, Marta
    Fernandez Alvira, Juan M.
    Andres, Vicente
    Bueno, Hector
    Collier, Timothy
    Van de Werf, Frans
    Perel, Pablo
    Rodriguez-Manero, Moises
    Alonso Garcia, Angeles
    Proietti, Marco
    Schoos, Mikkel M.
    Simon, Tabassome
    Fernandez Ferro, Jose
    Lopez, Nicolas
    Beghi, Ettore
    Bejot, Yannick
    Vivas, David
    Cordero, Alberto
    Ibanez, Borja
    Fuster, Valentin
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 967 - 977
  • [34] Polypill Strategy in Secondary Cardiovascular Prevention
    Stoschitzky, Kurt
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (23): : 2196 - 2198
  • [35] A polypill for cardiovascular disease prevention with a focus on non-alcohol steatohepatitis
    Joseph, Philip
    Yusuf, Salim
    EUROPEAN HEART JOURNAL, 2022, 43 (21) : 2034 - 2036
  • [36] Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population
    Kohli-Lynch, Ciaran N.
    Moran, Andrew E.
    Kazi, Dhruv S.
    Bibbins-Domingo, Kirsten
    Jordan, Neil
    French, Dustin
    Zhang, Yiyi
    Wang, Thomas J.
    Bellows, Brandon K.
    JAMA CARDIOLOGY, 2025, 10 (03) : 224 - 233
  • [37] WHATEVER HAPPENED TO THE POLYPILL? Polypill is not just for cardiovascular disease
    Cafferty, Fay H.
    Langley, Ruth E.
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [38] The polypill strategy in cardiovascular disease prevention: It's time for its implementation
    Di Fusco, Stefania Angela
    Aquilani, Stefano
    Spinelli, Antonella
    Alonzo, Alessandro
    Matteucci, Andrea
    Castello, Lorenzo
    Imperoli, Giuseppe
    Colivicchi, Furio
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 79 : 37 - 40
  • [39] Fixed-Dose Combination Therapy (Polypill) for the Prevention of Cardiovascular Disease
    Huffman, Mark D.
    de Cates, Angharad N.
    Ebrahim, Shah
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (19): : 2030 - 2031
  • [40] Polypill to fight cardiovascular disease - Cost effectiveness of statins for primary prevention of cardiovascular events is questionable
    Messori, A
    Santarlasci, B
    Trippoli, S
    Vaiani, M
    BRITISH MEDICAL JOURNAL, 2003, 327 (7418): : 808 - 809
12345